SG11201804601TA - Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine - Google Patents
Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amineInfo
- Publication number
- SG11201804601TA SG11201804601TA SG11201804601TA SG11201804601TA SG11201804601TA SG 11201804601T A SG11201804601T A SG 11201804601TA SG 11201804601T A SG11201804601T A SG 11201804601TA SG 11201804601T A SG11201804601T A SG 11201804601TA SG 11201804601T A SG11201804601T A SG 11201804601TA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- pct
- methods
- rule
- publication
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562268758P | 2015-12-17 | 2015-12-17 | |
| PCT/US2016/067161 WO2017106639A1 (en) | 2015-12-17 | 2016-12-16 | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201804601TA true SG11201804601TA (en) | 2018-07-30 |
Family
ID=59057623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201804601TA SG11201804601TA (en) | 2015-12-17 | 2016-12-16 | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US9834519B2 (es) |
| EP (2) | EP4015508A1 (es) |
| JP (2) | JP6940504B2 (es) |
| KR (1) | KR20180085814A (es) |
| CN (2) | CN114874149A (es) |
| AU (2) | AU2016369520B2 (es) |
| BR (1) | BR112018012325A2 (es) |
| CA (1) | CA3006077A1 (es) |
| EA (1) | EA201891431A1 (es) |
| HK (1) | HK1255014A1 (es) |
| IL (1) | IL259557A (es) |
| MX (2) | MX2020012771A (es) |
| NZ (1) | NZ742785A (es) |
| SG (1) | SG11201804601TA (es) |
| TW (1) | TWI748972B (es) |
| WO (1) | WO2017106639A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201804601TA (en) | 2015-12-17 | 2018-07-30 | Arqule Inc | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
| IL259556B2 (en) * | 2015-12-17 | 2023-09-01 | Arqule Inc | Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds |
| CN110669015A (zh) * | 2018-07-03 | 2020-01-10 | 上海喀露蓝科技有限公司 | 一种fgfr抑制剂的制备方法 |
| US10878412B2 (en) * | 2019-05-13 | 2020-12-29 | Truist Bank | In-line verification of transactions |
| WO2022053708A1 (en) | 2020-09-14 | 2022-03-17 | Basilea Pharmaceutica International AG | Pharmaceutical combinations for use in the treatment of gastric adenocarcinoma |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| WO1998028281A1 (en) | 1996-12-23 | 1998-07-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| US7786132B2 (en) * | 2004-12-17 | 2010-08-31 | Amgen Inc. | Aminopyrimidine compounds and methods of use |
| WO2008083356A1 (en) | 2006-12-29 | 2008-07-10 | Rigel Pharmaceuticals, Inc. | Substituted triazoles useful as axl inhibitors |
| GB2449293A (en) * | 2007-05-17 | 2008-11-19 | Evotec | Compounds having Hsp90 inhibitory activity |
| KR101714799B1 (ko) * | 2008-12-30 | 2017-03-09 | 아르퀼 인코포레이티드 | 치환된 5,6-디히드로-6-페닐벤조［ｆ］이소퀴놀린-2-아민 화합물 |
| EP2643314B1 (en) | 2010-11-25 | 2016-07-13 | ratiopharm GmbH | Novel salts and polymorphic forms of afatinib |
| US8815854B2 (en) * | 2011-06-24 | 2014-08-26 | Arqule, Inc. | Substituted imidazopyridinyl compounds |
| SG11201607772WA (en) * | 2014-03-31 | 2016-10-28 | Debiopharm Int Sa | Fgfr fusions |
| SG11201804601TA (en) * | 2015-12-17 | 2018-07-30 | Arqule Inc | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine |
| IL259556B2 (en) | 2015-12-17 | 2023-09-01 | Arqule Inc | Solid forms of substituted 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine compounds |
-
2016
- 2016-12-16 SG SG11201804601TA patent/SG11201804601TA/en unknown
- 2016-12-16 EP EP21216064.2A patent/EP4015508A1/en active Pending
- 2016-12-16 CN CN202210565751.2A patent/CN114874149A/zh active Pending
- 2016-12-16 NZ NZ742785A patent/NZ742785A/en not_active IP Right Cessation
- 2016-12-16 KR KR1020187020433A patent/KR20180085814A/ko not_active Application Discontinuation
- 2016-12-16 EA EA201891431A patent/EA201891431A1/ru unknown
- 2016-12-16 MX MX2020012771A patent/MX2020012771A/es unknown
- 2016-12-16 EP EP16876767.1A patent/EP3390368A4/en not_active Withdrawn
- 2016-12-16 MX MX2018007415A patent/MX2018007415A/es unknown
- 2016-12-16 CA CA3006077A patent/CA3006077A1/en active Pending
- 2016-12-16 CN CN201680081965.5A patent/CN108602779A/zh active Pending
- 2016-12-16 AU AU2016369520A patent/AU2016369520B2/en not_active Ceased
- 2016-12-16 TW TW105141874A patent/TWI748972B/zh active
- 2016-12-16 JP JP2018531343A patent/JP6940504B2/ja active Active
- 2016-12-16 BR BR112018012325A patent/BR112018012325A2/pt not_active Application Discontinuation
- 2016-12-16 US US15/381,418 patent/US9834519B2/en active Active
- 2016-12-16 WO PCT/US2016/067161 patent/WO2017106639A1/en active Application Filing
-
2017
- 2017-11-01 US US15/800,648 patent/US10093632B2/en active Active
-
2018
- 2018-05-23 IL IL259557A patent/IL259557A/en unknown
- 2018-11-06 HK HK18114135.7A patent/HK1255014A1/zh unknown
-
2019
- 2019-04-22 US US16/390,205 patent/US10766868B2/en not_active Expired - Fee Related
- 2019-10-03 US US16/592,003 patent/US11279679B2/en active Active
-
2021
- 2021-04-28 AU AU2021202610A patent/AU2021202610B2/en not_active Ceased
- 2021-09-02 JP JP2021142864A patent/JP2021191782A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018537495A (ja) | 2018-12-20 |
| AU2021202610A1 (en) | 2021-05-27 |
| JP6940504B2 (ja) | 2021-09-29 |
| CA3006077A1 (en) | 2017-06-22 |
| TW201733992A (zh) | 2017-10-01 |
| EA201891431A1 (ru) | 2018-11-30 |
| EP4015508A1 (en) | 2022-06-22 |
| US20170174637A1 (en) | 2017-06-22 |
| WO2017106639A1 (en) | 2017-06-22 |
| CN114874149A (zh) | 2022-08-09 |
| JP2021191782A (ja) | 2021-12-16 |
| EP3390368A1 (en) | 2018-10-24 |
| CN108602779A (zh) | 2018-09-28 |
| NZ742785A (en) | 2023-06-30 |
| US10093632B2 (en) | 2018-10-09 |
| AU2016369520B2 (en) | 2021-02-18 |
| KR20180085814A (ko) | 2018-07-27 |
| US9834519B2 (en) | 2017-12-05 |
| AU2016369520A1 (en) | 2018-06-07 |
| IL259557A (en) | 2018-07-31 |
| MX2018007415A (es) | 2018-11-09 |
| TWI748972B (zh) | 2021-12-11 |
| US11279679B2 (en) | 2022-03-22 |
| AU2021202610B2 (en) | 2022-06-02 |
| US10766868B2 (en) | 2020-09-08 |
| HK1255014A1 (zh) | 2019-08-02 |
| EP3390368A4 (en) | 2019-07-03 |
| MX2020012771A (es) | 2022-10-04 |
| US20200102276A1 (en) | 2020-04-02 |
| BR112018012325A2 (pt) | 2018-12-04 |
| US20190241527A1 (en) | 2019-08-08 |
| US20180065937A1 (en) | 2018-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201811491YA (en) | Quinazoline and indole compounds to treat medical disorders | |
| SG11201909955XA (en) | Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies | |
| SG11201909949XA (en) | Targeted immunotolerance | |
| SG11201804601TA (en) | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201804758QA (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| SG11201810579YA (en) | Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders | |
| SG11201804373VA (en) | Compositions and methods for immunooncology | |
| SG11201907023UA (en) | Method of reducing neutropenia | |
| SG11201908604YA (en) | Fused imidazo-piperidine jak inhibitor compound | |
| SG11201900163PA (en) | Macrocycle kinase inhibitors | |
| SG11201805709RA (en) | Anti-pro/latent myostatin antibodies and methods of use thereof | |
| SG11201804856VA (en) | C-terminal lysine conjugated immunoglobulins | |
| SG11201903287PA (en) | Anti-respiratory syncytial virus antibodies, and methods of their generation and use | |
| SG11201808566WA (en) | Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide | |
| SG11201907434RA (en) | Compositions and methods for immunooncology | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201909376TA (en) | Crystalline forms of a jak inhibitor compound | |
| SG11201806401YA (en) | G protein-coupled receptor (gpcr) modulation by imipridones | |
| SG11201907356SA (en) | Piperidine-substituted mnk inhibitors and methods related thereto | |
| SG11201901251SA (en) | Aminopyrimidines as alk inhibitors | |
| SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
| SG11201909807TA (en) | Methods of manufacturing of niraparib |